- ►bentham.org [PDF] L Fritsche, C Weigert, HU Haring, R … - Current medicinal …, 2008 - ingentaconnect.com Department of Internal Medicine 4, Div. of Clinical Chemistry and Pathobiochemistry, Central
Laboratory, University Hospital Tue- bingen, D-72076 Tuebingen, Germany Abstract: The liver
plays a key role in glucose homeostasis, lipid and energy metabolism. Its function is ... Cited by 10 - Related articles - BL Direct - All 5 versions
TT Wang, SY Hu, HD Gao, GY Zhang, CZ Liu, JB … - Annals of …, 2008 - journals.lww.com Reprints: Eldo Ermenegildo Frezza, MD, MBA, FACS, Department of Surgery, Division of General
Surgery, Texas Tech University Health Sciences Center, 3601, 4th Street, MS 8312,
Lubbock, Texas 79430. E-mail: eldo.frezza@ttuhsc.edu or San Yuan Hu, MD, PhD, ... Cited by 9 - Related articles - BL Direct - All 3 versions
- ►physiology.org ET Parlevliet, AC Heijboer, JP Schroder- … - American Journal of …, 2008 - Am Physiological Soc We evaluated the acute effects of OXM on glucose metabolism in diet-induced insulin-resistant
male C57Bl/6 mice. To determine the effects on glucose tolerance, mice were intraperitoneally
injected with OXM (0.75, 2.5, or 7.5 nmol) or vehicle prior to an ip glucose tolerance test. ... Cited by 4 - Related articles - BL Direct - All 3 versions
Y Lee, MK Kwon, ES Kang, YM Park, SH … - Journal of Gene …, 2008 - interscience.wiley.com Glucagon-like peptide-1 (GLP-1) is a gut-derived incretin hormone that plays an important role
in glucose homeostasis. Its functions include glucose-stimulated insulin secretion, suppression
of glucagon secretion, deceleration of gastric emptying, and reduction in appetite and ... Cited by 2 - Related articles - BL Direct - All 4 versions
SL Samson, EV Gonzalez, V Yechoor, M … - … therapy: the journal …, 2008 - pubmedcentral.nih.gov Exendin 4 (Ex4) is a glucagon-like peptide-1 receptor (GLP- 1R) agonist which is available as
a short-acting injectable treatment for type 2 diabetes. Our aim was to characterize the long-term
effects of elevated steady-state levels of Ex4 provided by in vivo gene therapy. We ... Cited by 1 - Related articles - All 5 versions
- ►ahajournals.org DJ Hausenloy, DM Yellon - Circulation: Heart Failure, 2008 - Am Heart Assoc The number of diabetic patients is increasing at an alarming rate and, according to the World
Health Organisation, is estimated to reach 300 million worldwide by the year 2025. Coronary
heart disease is the leading cause of death in these patients. Diabetic patients are 2 to 3 ... Cited by 1 - Related articles
G Garcia-Soria, G Gonzalez-Galvez, GM … - Diabetes, obesity & …, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 1 - Related articles - All 4 versions
S Forbes, S Robinson, KH Parker, IA MacDonald, … - European Journal of …, 2009 - nature.com Insulin sensitivity was similar in the previous GDM compared with control groups: (mean
sem) 29.1 3.2 vs 30.9 1.6 mg/l/min. The early (0–30 min) PPT response was diminished and
delayed in women with previous GDM compared with controls: (10 2 vs 15 1 kJ, P=0.04); ... Related articles - All 3 versions
